From: Cardiac hypertrophy in chronic kidney disease—role of Aldosterone and FGF23
Authors | Subjects/animals, n | Iron deficiency and FGF23 | Ref. |
---|---|---|---|
Humans | |||
Bozentowics- Wikarek M et al. | 3780 elderly | Low iron levels are associated with increased FGF23 levels. FGF23 levels were nearly linearly increased by 0.285 pg/mL for each unit of serum iron decrease in patients with serum iron levels < 59 ng/mL, | [144] |
Lewerin C et al. | 1010 elderly | FGF 47.4 μmol/L (transferrin saturation (TS) < 15%) vs 41.9 μmol/L (TS > 15%) | [145] |
Braithwaite V. et al. | 79 children non-CKD | Iron status is a negative predictor of plasma FGF23 concentration. Improvements in iron status following iron supplementation are associated with a significant decrease in FGF23 concentration. | [146] |
Deger SM et al. | 73 hemodialysis | There was a negative relationship between iron administration and serum iFGF23 level in a dialysis population | [150] |
Yamashita K et al. | 31 hemodialysis | Serum FGF23 was reduced from 1820 pg/mL (342-4370) to 1240 pg/mL (214-2840) after 3-month treatment with sodium ferrous citrate. | [151] |
Takeda Y, et al | 27 hemodialysis | Intravenous saccharated ferric oxide induces further increase in FGF23 levels. | [152] |
Iguchi A et al | 124 hemodialysis | Serum FGF23 level decreased from 2000 pg/mL (1300-3471.4) to 1771.4 pg/mL (1142.9-2342.9) after switching from sevelamer to ferric citrate hydrate. | [154] |
Animals | |||
David V et al | Mice | Three-week low iron diet intake resulted in significantly increased levels of bone FGF23 mRNA. Functional iron deficiency with hepcidin injection caused increased bone expression of FGF23 mRNA. | [147] |
Hanudel MR et al | Adenin-induced CKD mice | Eight-week adenine-containing and low iron diet intake increased the bone FGF23 mRNA levels. | [148] |
Farrow EG et al. | Mice | Mice receiving low-iron diet had significantly elevated bone Fgf23 mRNA. | [149] |
Gravesen E et al. | Non-iron depleted uremic rats | Intravenous iron isomaltoside and ferric carboxymaltose had no effect on plasma levels of FGF23 and phosphate. | [153] |